AI |
artificial intelligence |
AUC |
area under curve |
BFPS |
block filtering post-pruning search |
ccpRCC |
clear cell papillary renal cell carcinoma |
ccRCC |
clear cell renal cell carcinoma |
chRCC |
chromophobe renal cell carcinoma |
CNA |
copy number alteration |
CNN |
convolutional neural network |
CT |
computed tomography |
DAG-SVM |
Directed Acyclic Graph Support Vector Machine |
DCNN |
deep convoluted neural network |
DFS |
disease free survival |
DL |
deep learning |
DNN |
deep neural network |
EGFR |
Epidermal growth factor receptor |
FCNN |
fully-connected neural network |
grad-CAM |
gradient-weighted class activation mapping |
IMDC |
International Metastatic Renal Cell Carcinoma Database Consortium |
KRAS |
V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
LASSO |
Least Absolute Shrinkage and Selection Operator |
lmQCM |
local maximum quasi-clique merging |
ML |
machine learning |
mRCC |
metastatic renal cell carcinoma |
MRI |
magnetic resonance imaging |
MSKCC |
Memorial Sloan Kettering Cancer Center |
N.A. |
not applicable |
NP |
normal parenchyma |
NT |
normal tissue |
OS |
overall survival |
PFS |
Progression-free survival |
pRCC |
papillary renal cell carcinoma |
RCC |
renal cell carcinoma |
ResNet |
residual neural network architecture |
RMB |
renal mass biopsy |
RO |
renal oncocytoma |
SVM |
support vector machine |
TCGA |
The Cancer Genome Atlas |
TKI |
Tyrosine kinase inhibitors |
UISS |
UCLA Integrated Staging System for renal cell carcinoma |
VEGFR-TKI |
VEGF receptor-tyrosine kinase inhibitors |
VHL |
Von-Hippel-Lindau tumor suppressor |
WSI |
whole slide imaging |